reversed-phase chromatography raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-09-18. Anything still debated is marked as such rather than presented as settled.
Biological interest in this peptide centers on its relationship to actin dynamics. Thymosin beta-4 binds monomeric actin through an LKKTET motif, and a short sequence carrying that motif can compete with other actin-binding proteins in cell-free preparations. Investigators propose that such competition shifts the balance between filament assembly and disassembly, which in turn affects how readily a cell extends protrusions and migrates. Most of the supporting observations come from cultured cells and purified protein systems rather than from intact organisms.
Animal work has examined the peptide in models of cardiac injury, skin wounding, and corneal repair, with reported outcomes covering cell migration, inflammatory cell influx, and tissue remodeling. Several of those experiments used the full-length protein or longer fragments instead of the seven-residue sequence, which makes direct comparison between reports difficult. Results are generally described as tissue-dependent, and effect sizes vary considerably across laboratories. Independent replication is uneven, so the overall picture is incomplete rather than settled.
Controlled human trials of the short fragment are scarce. Much of what appears in review articles is extrapolated from animal models or from studies of the parent protein, and literature searches return a larger body of cardiac and ophthalmic work on thymosin beta-4 than on the abbreviated peptide. Regulatory treatment differs by jurisdiction, and in several countries the material is handled as a research chemical rather than an approved therapeutic. Statements about human benefit should be read as provisional.
Thymosin beta-4 itself is a natural peptide of 43 residues found in many cell types and body fluids. Its best-characterised function is binding and sequestering actin monomers, which influences cytoskeletal dynamics. The sequence most often associated with TB-500, LKKTETQ, corresponds to part of that actin-binding region. A different fragment, Ac-SDKP, is also derived from the same parent peptide and is studied in its own right, which is one reason discussions of thymosin fragments can become confusing. The two are structurally distinct and are not interchangeable.
Interest in the fragment grew during the 1990s and 2000s, when it moved from laboratory work into sports and supplement markets. Anti-doping bodies added thymosin beta-4 fragments to prohibited lists, and a small number of adverse analytical findings have been reported in competition testing. Published controlled human trials remain scarce. Most mechanistic evidence comes from cell culture and animal models, and those studies examine endpoints such as cell migration, wound closure and inflammation markers. That evidence supports research interest but does not establish clinical benefit, and broad regenerative claims should be read as unverified.
TB-500 is a short synthetic peptide sold under a trade name rather than a systematic chemical name. Suppliers usually describe it as a fragment of thymosin beta-4 and ship it as a lyophilised powder intended for laboratory use. Because the label is commercial, the exact sequence attributed to it is not fully consistent across catalogues, and some listings present a seven-residue peptide while others describe related fragments of similar length. It is not an approved medicine in any major jurisdiction, and it is handled as a research chemical.
| Property | Value | Notes |
|---|---|---|
| Common synonyms | Thymosin beta-4 fragment; TB4 fragment | Naming is inconsistent across suppliers and publications |
| Reported sequence | Ac-LKKTETQ | Corresponds to residues 17-23 of the parent protein |
| Frequently cited registry number | 77591-33-4 | Associated with full-length thymosin beta-4 rather than the fragment |
| Common supplied form | Freeze-dried solid | Often presented as an acetate or trifluoroacetate salt |
| Regulatory treatment | Varies by country | Frequently handled as a research chemical; not broadly approved as a therapeutic |
TB-500 is a synthetic peptide whose sequence corresponds to a short fragment near the N-terminus of thymosin beta-4, a small protein present in most mammalian cells. The fragment is commonly cited as containing the actin-binding region of the parent molecule, which is why it appears in laboratory work on cell migration and tissue repair. Suppliers distribute it as a lyophilised powder intended for research use. Its identity is defined by amino acid sequence and by the presence of an acetyl group on the N-terminal residue.
Full-length thymosin beta-4 consists of roughly forty-three amino acids and ranks among the more abundant small proteins in the cytoplasm. The fragment is much shorter, so it cannot reproduce every function attributed to the intact molecule. In cell culture, short actin-binding motifs can interfere with filament dynamics and cell movement, but such observations come from controlled experiments rather than from whole-animal work. Whether a truncated fragment produces the same effects as the parent protein remains an open question.
Interest in the peptide grew during the 2000s and 2010s, when studies of tendon and ligament injuries in horses reported changes in lesion size after treatment. Those reports circulated widely outside the scientific literature and shaped much of the current online discussion. Subsequent reviews noted inconsistent study design, small groups, and a shortage of independent replication. Popular descriptions often blur the line between the fragment, the complete protein, and unrelated growth factors, which complicates comparisons across sources.
Lyophilised peptide is normally reconstituted with sterile water or a neutral buffer shortly before use. Because repeated freeze-thaw cycles can degrade the material, dividing a reconstituted solution into single-use aliquots is a common practice. Working solutions are usually kept cold and protected from light. The exact shelf life depends on concentration, buffer composition, and handling, so it is often determined empirically rather than assumed.
Peptide bonds are susceptible to hydrolysis under extreme pH and to enzymatic cleavage if proteases are present. Heat, oxidising agents, and prolonged exposure to light also contribute to loss of material. Aggregation can occur at high concentrations or in certain buffer systems, and it may not be visible to the eye. Storage at -20 C or below is typical for both powder and aliquoted solutions, and desiccation of the powder is preferred.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography together with mass spectrometry. The chromatogram provides a purity estimate as a percentage of total peak area, while the mass spectrum confirms that the observed mass matches the expected value. Amino acid analysis or tandem mass spectrometry sequencing can provide additional confirmation. Reported purity figures depend on the column, gradient, and detection wavelength, so values from different laboratories are not directly comparable without method details.
== Background == Beginning life as Claus Cecil Borberg, Bülow was the son of Danish author and playwright Svend Borberg (1888–1947) and his wife, Jonna von Bülow-Plüskow (1900–1959). His father was accused, though later cleared, of being a Nazi collaborator for his activities during the Second World War in the German occupation of Denmark. After graduating from university with a degree in law and becoming an apprentice in the legal profession, Claus chose to be known by his maternal surname, Bülow, instead of his father's surname, Borberg. His mother was the daughter of Frits Bülow von Plüskow, Danish Minister of Justice from 1910 to 1913, president of the upper chamber of the Danish Parliament from 1920 to 1922 and a member of the old Dano-German noble Bülow family, originally from Mecklenburg. Von Bülow graduated from Trinity College, Cambridge, and practised law in London in the 1950s before working as a personal assistant to J. Paul Getty. While he had a variety of duties for Getty, Bülow became very familiar with the economics of the oil industry. Getty wrote that Bülow showed "remarkable forbearance and good nature" as his occasional whipping boy, and Bülow remained with Getty until 1968. On 6 June 1966, von Bülow married Sunny, the American ex-wife of Prince Alfred von Auersperg. He worked on and off as a consultant to oil companies. Sunny already had a son and a daughter from her first marriage; together, she and Bülow had a daughter, Cosima von Bülow, born on 15 April 1967 in New York City.
== Structure == hPL molecular mass is 22 125 Da and contains single chain consisting of 191 amino acid residues that are linked by two disulfide bonds and the structure contains 8 helices. A crystal structure of hPL was determined by X-ray diffraction to a resolution of 2.0 Å.
Surface tension theory – according to this theory, emulsification takes place by reduction of interfacial tension between two phases Repulsion theory – According to this theory, the emulsifier creates a film over one phase that forms globules, which repel each other. This repulsive force causes them to remain suspended in the dispersion medium Viscosity modification – emulgents like acacia and tragacanth, which are hydrocolloids, as well as PEG (polyethylene glycol), glycerine, and other polymers like CMC (carboxymethyl cellulose), all increase the viscosity of the medium, which helps create and maintain the suspension of globules of dispersed phase
Re2O7 + 17 CO → Re2(CO)10 + 7 CO2 If metal oxides are used carbon dioxide is formed as a reaction product. In the reduction of metal chlorides with carbon monoxide phosgene is formed, as in the preparation of osmium carbonyl chloride from the chloride salts. Carbon monoxide is also suitable for the reduction of sulfides, where carbonyl sulfide is the byproduct.
Sources: en.wikipedia.org
Trends in obesity prevalence show no increase among youth since 2003–2004, but trends do show increases in both adults and youth from 1999 to 2000 through 2013–2014. No significant differences between 2011 and 2012 and 2013–2014 were seen in either youth or adults. Under pressure from parents and anti-obesity advocates, many school districts moved to ban sodas, junk foods, and candy from vending machines and cafeterias. State legislators in California, for example, passed laws banning the sale of machine-dispensed snacks and drinks in elementary schools in 2003, despite objections by the California-Nevada Soft Drink Association. The state followed more recently with legislation to prohibit their soda sales in high schools starting July 1, 2009, with the shortfall in school revenue to be compensated by an increase in funding for school lunch programs. A similar law passed by the Connecticut General Assembly in June 2005 was vetoed by governor Jodi Rell, who stated the legislation "undermines the control and responsibility of parents with school-aged children." In mid-2006, the American Beverage Association (including Cadbury, Coca-Cola, and PepsiCo) agreed to a voluntary ban on the sale of all high-calorie drinks and all beverages in containers larger than 8, 10 and 12 ounces in elementary, middle and high schools, respectively. There have been many strategies to try to control obesity issues. One cost-effective population-level change is taxes on sugary drinks. Interventions such as taxes can be a powerful way to improve the economic landscape of the food environment.
== Organizations == RPC Group, UK packaging company Recorded Picture Company, a British film-production company Reformed Presbyterian Church (disambiguation), denominations following a Presbyterian form of Christianity Regent's Park College, a permanent private hall of Oxford University RPC Fort (Research and Production Company Fort), a Ukrainian weapons manufacturer Research Policy Council, the executive management team for the Congressional Research Service, a division of the Library of Congress Royal Parks Constabulary, a police force which patrolled the eight Royal Parks of London and a number of other locations in London, 1974–2004 RPC, Inc., a North American oil services business RPC, a Brazilian television network affiliated with TV Globo in the state of Paraná
=== The Ait Soussan organisation === The Ait Soussan organisation is a criminal organisation led by Houssine Ait Soussan. He is a major drug trafficker who also used to own the Dutch football-club ZVV 't Knooppunt. Houssine Ait Soussan is notably a prominent figure within the Moroccan mafia in the Netherlands and Belgium, and he was also allied with the Bouyakhrichan organisation. The Ait Soussan organisation is responsible for distributing tons of cocaine across all of Western Europe. Houssine Ait Soussan is also considered to be one of the original participating figures within the Mocro-War, which was sparked after a missing shipment of cocaine in the port of Antwerp. As a result of this, Houssine Ait Soussan is believed to be behind the kidnapping of Abdelkader "the Jew" Bouker, a major Belgian-Moroccan drug trafficker who worked closely together with the Israeli mafia, and went missing in 2016. He was also believed to be behind the kidnapping of Younes El Ballouti, the younger brother of Othman El Ballouti, who is considered to be one of the biggest drug lords in Belgium. Houssine Ait Soussan allegedly kidnapped him as revenge, because Colombian cartels preferred to work with the El Ballouti clan instead of his organisation. Houssine Ait Soussan was for many years wanted by the Dutch and Belgian authorities for his involvement in numerous of assassinations and kidnappings, which mostly took place in Antwerp and Brussels. He orchestrated his kidnappings and assassinations from Central America, to stay off the radar from the European police.
Sources: en.wikipedia.org
The leading proposal involves sequestration of monomeric actin, which would alter cytoskeletal turnover and cell movement. The actin-binding motif shared with the parent protein is central to that idea. Direct confirmation in whole organisms remains limited.
Very few controlled human studies focus on the seven-residue sequence itself. Most clinical data concern the full-length protein in cardiac or ophthalmic settings. Conclusions drawn for one form should not be assumed to transfer to the other.
Detection normally relies on reversed-phase liquid chromatography paired with mass spectrometry. Chromatographic retention time establishes the expected elution window, and the mass spectrum confirms the molecular ion. Immunoassays exist but can cross-react with related peptides.
No. Thymosin beta-4 is a 43-residue natural peptide, while TB-500 is a commercial label applied to a short synthetic fragment of it. The two differ in length, sequence coverage and how they are handled in the laboratory.